Deloitte Legal is proud to have assisted Revision Implant with its €4 million euro investment round.
Belgian neurotech startup ReVision Implant has raised €4M in an oversubscribed round from private investors, clearing the path to first-in-human clinical trials scheduled for Q3 2026.
The Deloitte Legal team comprised Christoph Michiels and Tine Bassens.
Find out more in the press release.